Spencer Kobren’s The Bald Truth 9/4/11

This week on The Bald Truth: Joe from Staten Island calls in to rant about recent internet attacks on Spencer, himself and company’s like RepliCel and Histogen, as well as to provide his weekly hair loss update. George from Mobile finally touches base with TBT after being MIA for 2 weeks. Andrew Zarian calls in during the middle of a panic attack…Spencer’s advice: “hit the gym and stop tuning in to TBT.”

Sunkast from the GFQ Network also calls in to ask if his eyebrow will grow back after accidently shaving it off in what must have been one interesting evening. Just another classic TBT that you won’t want to miss!

Spencer Kobren’s The Bald Truth is internationally syndicated through the GFQ Network

Histogen Update – Spencer Kobren Speaks With Dr. Craig Ziering About Possible Launch Date of Histogen’s (HSC) And More

Histogen’s Hair Stimulating Complex (HSC) is considered as cutting edge as it gets in the fight against male and female pattern hair loss.

A proprietary liquid formula created by the culturing of newborn fibroblasts in an embryonic-like environment, Histogen’s (HSC) is the first naturally stabilized and bioactive formulation of Wnt proteins and natural cofactors being developed and evaluated as an injectable product for hair growth.

Craig L. Ziering, D.O., FAOCD, Histogen’s principal clinical investigator joins Spencer Kobren to discuss Histogen’s latest developments.

Listen to the interview

Histogen’s HSC Shows Continued Hair Growth At One Year – Listen to Exclusive TBT Interview

Exclusive interview with Histogen Inc. CEO and Founder Dr. Gail Naughton:

HSC Trial Shows Continued Significant Hair Growth at One Year Follow-up

Histogen to present one year clinical trial data at Society for Investigative Dermatology Annual Meeting

SAN DIEGO, April 13, 2010 – Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn cells grown under embryonic conditions, today announced the one year data findings of its Hair Stimulating Complex (HSC) pilot clinical trial. Statistically significant new hair growth was seen in HSC-treated subjects at this follow-up timepoint, one year after their single treatment with HSC. [Read more]

Tonight on the Bald Truth 8/9/09 – Good News for Hair Loss Sufferers

Histogen, Inc., the regenerative medicine company that develops products derived from newborn fibroblasts, is apparently seeing some impressive results after conducting preliminary clinical trials of their HSC human hair regrowth product. These results were announced at this year’s ISHRS conference that took place in Amsterdam this past July. The buzz on the street is that Histogen just might be onto something big!

Craig L. Ziering, D.O., FAOCD,  the   principal investigator of the clinical trial  will be joining us tonight to discuss his findings and to explain how Histogen’s HSC Human Hair Growth Product, might someday soon  be used to effectively treat Androgenic Alopecia.

This is a show you won’t want to miss!